5% Dextrose and 0.45% Sodium Chloride Injection, USP, 1000 mL VisIV Container, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7926-48
Published July 3, 2013 · Recall initiated: May 4, 2012
Summary
FDA records drug Class II recall D-615-2013, published July 3, 2013 and initiated May 4, 2012. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 74,256 units; Lot: Lot #: 11-161-JT, Exp 11/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Hospira Inc.
- Distributor
- Nationwide Puerto Rico, U.S. Virgin Island, Libya, Saudi Arabia
- Lot
- Lot #: 11-161-JT, Exp 11/13
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAInfant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per carton, RxMay 31, 2017
- FDAMinibore Extension Set, 59 Inch with Spin Lock Collar, Non-DEHP, Latex-Free Intended use: For theJanuary 18, 2017
- FDAFentanyl Citrate Injection, USP, 100 mcg Fentanyl/ 2mL, Single Dose, 50 mcg/mL, Rx only, Hospira, Inc., LakeNovember 30, 2016
- FDASymbiq Two Channel Infuser; an Rx medical device infusion pump used to administer I.V. fluids. List numberNovember 16, 2016
- FDA5% Dextrose Injection USP, a) 250 mL (NDC 0409-7922-02), b) 500 mL (NDC 0409-7922-30), by Hospira, Inc., LakeJuly 3, 2013
- FDA20% Dextrose Injection, USP, a) 500 mL in 1000 mL Partial-Fill Container (NDC 0409-7935-19), b) 500 mL VisIVJuly 3, 2013
Questions about this recall
Was 5% Dextrose and 0.45% Sodium Chloride Injection, USP, 1000 mL VisIV Container, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7926-48 recalled?
Yes. FDA published recall D-615-2013 on July 3, 2013. Reported hazard: Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags.
What should I do if I have this product?
Voluntary: Firm initiated · Letter